Alcanza Clinical Research, a mission-focused investigator site network, announces the acquisition of Accel Research Sites Network, a multi-specialty network headquartered in Florida, with additional sites in Alabama and Georgia. As a leader in medical research since 1998, Accel\u2019s network of 22 sites includes eight clinical research units and 14 embedded sites strategically placed in healthcare settings across the Southeast U.S.<\/p>\n
\u201cThe addition of Accel to the Alcanza network is part of our strategy to operate with greater scale and therapeutic specialization to reach more patient populations who are not traditionally presented with research participation opportunities,\u201d said Carlos Orantes, CEO of Alcanza. \u201cAccel\u2019s breadth of therapeutic expertise, reputation for on-time enrollment and their access to diverse patient populations are a perfect complement for Alcanza\u2019s growth portfolio.\u201d<\/p>\n
\u201cWe are looking for a partner with aligned vision to further our mission of patient-centric clinical research while reducing barriers to participation,\u201d said Dr. Lora Parahovnik, CEO of Accel. \u201cThat partner is Alcanza. This move will enable us to conduct clinical trials more efficiently, effectively, and inclusively than ever before. Together, we’ll be able to offer more opportunities for patients to participate in clinical research, and we’ll be better positioned to recruit and retain high-quality research staff.\u201d<\/p>\n
Accel\u2019s site operations will be integrated into Alcanza\u2019s centralized platform while retaining its name and brand identity.<\/p>\n
About Alcanza Clinical Research<\/strong> Alcanza Clinical Research, a mission-focused investigator site network, announces the acquisition of Accel Research Sites Network, a multi-specialty network headquartered in Florida, with additional sites in Alabama and Georgia. As a leader in medical research since 1998, Accel\u2019s network of 22 sites includes eight clinical research units and 14 embedded sites strategically placed in healthcare […]<\/p>\n","protected":false},"author":15,"featured_media":3273,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[372,358,399,400,355],"class_list":["post-3272","post","type-post","status-publish","has-post-thumbnail","hentry","category-company-news","tag-accel","tag-accel-research-sites","tag-alcanza","tag-alcanza-clinical-research","tag-clinical-research"],"acf":[],"yoast_head":"\n
\nAlcanza Clinical Research is an integrated network of research facilities focused on bringing clinical trial opportunities involving life-changing treatments and vaccines to all patients, especially those from under-represented communities. With locations in Alabama, Florida, Georgia, Massachusetts, Michigan, New Hampshire, South Carolina, and Virginia, we specialize in a range of conditions across allergy, cardiology, dermatology, endocrinology, immunology, infectious disease, neurology, ophthalmology, psychiatry, and respiratory therapeutic areas.<\/p>","protected":false},"excerpt":{"rendered":"